Bahar Aghighi, MD
Endocrinology · Los Altos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Aghighi’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A61454 · Current
Licensed to practise in California · since 1997 · expires 2029-01-31 · National University of Iran Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$173,104
Medicare paid this office $173,104 for 235 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, denosumab, 1 mg | 43 | $84,939 | None |
| Return visit (30+ min) | 185 | $32,653 | $108 |
| Long return visit (40+ min) | 26 | $4,742 | $169 |
| New patient visit (60+ min) | 17 | $3,230 | $190 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 19 | $2,687 | $134 |
See all 8 services
| Injection, denosumab, 1 mg | 43 | $84,939 | None |
| Return visit (30+ min) | 185 | $32,653 | $108 |
| Long return visit (40+ min) | 26 | $4,742 | $169 |
| New patient visit (60+ min) | 17 | $3,230 | $190 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 19 | $2,687 | $134 |
| Injection of drug or substance under skin or into muscle | 47 | $1,612 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | $1,543 | $30 |
| Short return visit (20+ min) | 11 | $710 | $65 |
Who their Medicare patients are
235 Original Medicare patients in 2024. Average age 75 · Women 82% · Also on Medicaid 11% · Health risk score 0.98. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 59% · Diabetes 27% · Chronic kidney disease 17% · Coronary heart disease 16% · Depression 16% · Cancer 15% · Atrial fibrillation 11% · COPD 9% · Heart failure 6% · Stroke 5%.
The office billed $487,498, Medicare allowed $224,799 and paid $173,104; for 9,243 services of 14 kinds; $123,061 of it was for drugs given in the office and $50,044 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 235 | 9,243 | 75 | 0.98 | $487,498 | $173,104 |
| 2023 | 231 | 8,028 | 74 | 1.02 | $439,093 | $152,812 |
| 2022 | 231 | 11,398 | 75 | 0.96 | $473,427 | $159,761 |
| 2021 | 251 | 7,141 | 74 | 0.96 | $393,959 | $135,069 |
| 2020 | 233 | 3,442 | 73 | 1.05 | $302,582 | $96,435 |
| 2019 | 220 | 3,346 | 73 | 1.17 | $273,114 | $79,277 |
| 2018 | 203 | 2,830 | 74 | 1.22 | $283,533 | $74,170 |
| 2017 | 202 | 1,946 | 72 | 1.22 | $260,344 | $68,748 |
| 2016 | 174 | 774 | 72 | 1.16 | $185,072 | $47,654 |
| 2015 | 98 | 500 | 69 | 1.02 | $116,109 | $30,600 |
| 2014 | 36 | 114 | 71 | 0.94 | $22,401 | $6,255 |
| 2013 | 294 | 904 | 71 | 1.14 | $227,869 | $57,262 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Injection, denosumab, 1 mg | 42 | $82,715 | None |
| Return visit (30+ min) | 187 | $33,760 | $112 |
| Long return visit (40+ min) | 27 | $4,912 | $169 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 16 | $2,118 | $132 |
| Injection of drug or substance under skin or into muscle | 45 | $1,453 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 21 | $1,318 | $31 |
2022: 8 services
| Injection, denosumab, 1 mg | 39 | $63,703 | None |
| Return visit (30+ min) | 166 | $26,250 | $109 |
| Long return visit (40+ min) | 24 | $4,354 | $161 |
| New patient visit (60+ min) | 22 | $3,540 | $161 |
| New patient visit (45+ min) | 18 | $2,859 | $159 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 12 | $1,604 | $134 |
| Injection of drug or substance under skin or into muscle | 45 | $1,520 | $14 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 19 | $1,093 | $31 |
2021: 8 services
| Injection, denosumab, 1 mg | 37 | $59,035 | None |
| Return visit (30+ min) | 167 | $29,041 | $114 |
| New patient visit (60+ min) | 35 | $7,024 | $201 |
| Long return visit (40+ min) | 37 | $6,723 | $156 |
| New patient visit (45+ min) | 28 | $4,047 | $145 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 16 | $2,377 | $140 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 23 | $1,916 | $32 |
| Injection of drug or substance under skin or into muscle | 40 | $1,091 | $14 |
2020: 11 services
| Injection, denosumab, 1 mg | 33 | $42,417 | None |
| Return visit (30+ min) | 152 | $24,186 | $94 |
| New patient visit (45+ min) | 41 | $5,991 | $146 |
| Long return visit (40+ min) | 35 | $4,841 | $127 |
| Telephone medical discussion with physician, 21-30 minutes | 31 | $4,398 | $102 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 26 | $3,304 | $127 |
| New patient visit (60+ min) | 15 | $2,640 | $176 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | $1,988 | $33 |
| Injection of drug or substance under skin or into muscle | 35 | $833 | $14 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $810 | $74 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 20 | $352 | $14 |
2019: 8 services
| Injection, denosumab, 1 mg | 31 | $42,902 | None |
| Return visit (30+ min) | 143 | $17,543 | $91 |
| New patient visit (45+ min) | 46 | $6,744 | $147 |
| Long return visit (40+ min) | 28 | $3,618 | $121 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 23 | $2,955 | $123 |
| New patient visit (60+ min) | 16 | $2,890 | $181 |
| Injection of drug or substance under skin or into muscle | 32 | $930 | $17 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 20 | $918 | $32 |
2018: 7 services
| Injection, denosumab, 1 mg | 25 | $33,699 | None |
| Return visit (30+ min) | 142 | $18,951 | $88 |
| New patient visit (45+ min) | 68 | $9,298 | $137 |
| Fine needle aspiration using imaging guidance | 30 | $6,282 | $140 |
| Long return visit (40+ min) | 19 | $2,549 | $127 |
| Ultrasonic guidance for needle placement | 30 | $1,646 | $51 |
| Injection of drug or substance under skin or into muscle | 25 | $824 | $21 |
2017: 7 services
| Return visit (30+ min) | 153 | $27,209 | $92 |
| Injection, denosumab, 1 mg | 16 | $18,722 | None |
| New patient visit (45+ min) | 63 | $8,988 | $143 |
| Fine needle aspiration using imaging guidance | 27 | $6,523 | $139 |
| Long return visit (40+ min) | 25 | $3,249 | $120 |
| Ultrasonic guidance for needle placement | 27 | $1,583 | $57 |
| Injection of drug or substance under skin or into muscle | 16 | $620 | $26 |
2016: 6 services
| Return visit (30+ min) | 116 | $20,196 | $91 |
| New patient visit (45+ min) | 79 | $11,415 | $144 |
| Fine needle aspiration using imaging guidance | 23 | $5,406 | $139 |
| Long return visit (40+ min) | 22 | $3,055 | $133 |
| Ultrasonic guidance for needle placement | 23 | $1,589 | $59 |
| Short return visit (20+ min) | 13 | $844 | $60 |
2015: 4 services
| Return visit (30+ min) | 64 | $13,099 | $96 |
| New patient visit (45+ min) | 53 | $8,121 | $153 |
| Fine needle aspiration using imaging guidance | 19 | $3,740 | $139 |
| Ultrasonic guidance for needle placement | 19 | $1,247 | $59 |
2014: 2 services
| Return visit (30+ min) | 22 | $2,755 | $95 |
| New patient visit (45+ min) | 13 | $1,973 | $152 |
2013: 6 services
| Return visit (30+ min) | 204 | $29,398 | $78 |
| New patient visit (45+ min) | 52 | $6,749 | $130 |
| Ultrasonic guidance for needle placement | 25 | $4,717 | $168 |
| Fine needle aspiration using imaging guidance | 25 | $3,273 | $117 |
| Short return visit (20+ min) | 54 | $2,744 | $44 |
| Injection of drug or substance under skin or into muscle | 11 | $435 | $22 |
Drugs they prescribed that Part D paid
$499,914
Pharmacies billed $499,914 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,449) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
749 generic and 648 brand-name prescriptions · $499,914 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 78 | $105,105 | $1,347 |
| Ozempic | 58 | $90,444 | $1,559 |
| Jardiance | 43 | $69,105 | $1,607 |
| Trulicity | 34 | $50,488 | $1,485 |
| Synjardy Xr | 15 | $24,160 | $1,611 |
See all 26 drugs
| Mounjaro | 78 | $105,105 | $1,347 |
| Ozempic | 58 | $90,444 | $1,559 |
| Jardiance | 43 | $69,105 | $1,607 |
| Trulicity | 34 | $50,488 | $1,485 |
| Synjardy Xr | 15 | $24,160 | $1,611 |
| Farxiga | 27 | $18,272 | $677 |
| Synthroid | 113 | $12,222 | $108 |
| Tresiba Flextouch U-100 | 19 | $8,779 | $462 |
| Novolog Flexpen | 21 | $4,717 | $225 |
| Levothyroxine | 281 | $3,200 | $11 |
| Nano 2nd Gen Pen Needle | 23 | $2,578 | $112 |
| Alendronate | 145 | $1,548 | $11 |
| Liothyronine | 37 | $1,281 | $35 |
| Levoxyl | 22 | $1,004 | $46 |
| Ultra-Fine Mini Pen Needle | 12 | $950 | $79 |
| Rosuvastatin | 44 | $675 | $15 |
| Humulin R | 13 | $453 | $35 |
| Humulin N | 13 | $453 | $35 |
| Metformin Hcl Er | 41 | $309 | $8 |
| Metformin | 61 | $301 | $5 |
| Glipizide Er | 11 | $143 | $13 |
| Atorvastatin | 45 | $139 | $3 |
| Lisinopril | 12 | $131 | $11 |
| Amlodipine Besylate | 19 | $59 | $3 |
| Glipizide | 13 | $46 | $4 |
| Dexamethasone | 14 | $12 | $1 |
Year by year
| 2024 | 1,449 | 224 | 0% (0) | 45% | $499,914 |
| 2023 | 1,351 | 214 | 0% (0) | 46% | $544,713 |
| 2022 | 1,311 | 201 | 0% (0) | 50% | $636,951 |
| 2021 | 1,421 | 213 | 0% (0) | 51% | $683,758 |
| 2020 | 1,137 | 193 | 0% (0) | 50% | $424,592 |
| 2019 | 994 | 175 | 0% (0) | 53% | $367,576 |
| 2018 | 1,078 | 160 | 0% (0) | 55% | $385,238 |
| 2017 | 1,194 | 146 | 0% (0) | 56% | $373,082 |
| 2016 | 870 | 132 | None | 46% | $169,183 |
| 2015 | 652 | 117 | 0% (0) | 50% | $142,716 |
| 2014 | 1,267 | 203 | 0% (0) | 52% | $228,679 |
| 2013 | 2,508 | 253 | 0% (0) | 51% | $368,581 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Ozempic | 74 | $137,616 | $1,860 |
| Trulicity | 74 | $105,057 | $1,420 |
| Jardiance | 53 | $84,891 | $1,602 |
| Novolog Flexpen | 31 | $32,955 | $1,063 |
| Synthroid | 93 | $11,310 | $122 |
| Tresiba Flextouch U-100 | 13 | $9,818 | $755 |
| Lantus Solostar | 13 | $5,961 | $459 |
| Levothyroxine | 272 | $4,818 | $18 |
| Cytomel | 11 | $3,616 | $329 |
| Nano 2nd Gen Pen Needle | 22 | $2,894 | $132 |
| Humulin N | 11 | $1,758 | $160 |
| Humulin R | 11 | $1,758 | $160 |
| Alendronate | 129 | $1,669 | $13 |
| Liothyronine | 29 | $1,420 | $49 |
| Levoxyl | 31 | $706 | $23 |
| Metformin Hcl Er | 48 | $700 | $15 |
| Atorvastatin | 57 | $514 | $9 |
| Hydrocortisone | 13 | $425 | $33 |
| Metformin | 50 | $424 | $8 |
| Rosuvastatin | 19 | $379 | $20 |
| Lisinopril | 16 | $252 | $16 |
| Glipizide | 16 | $171 | $11 |
| Losartan | 12 | $139 | $12 |
| Amlodipine Besylate | 11 | $113 | $10 |
2022: 28 drugs
| Ozempic | 99 | $171,995 | $1,737 |
| Jardiance | 70 | $100,153 | $1,431 |
| Trulicity | 58 | $92,272 | $1,591 |
| Forteo | 14 | $53,245 | $3,803 |
| Novolog Flexpen | 25 | $35,756 | $1,430 |
| Tymlos | 12 | $30,475 | $2,540 |
| Farxiga | 14 | $16,520 | $1,180 |
| Lantus Solostar | 29 | $14,491 | $500 |
| Humalog Kwikpen U-100 | 12 | $11,314 | $943 |
| Synthroid | 87 | $9,601 | $110 |
| Novolog Mix 70-30 Flexpen | 11 | $5,381 | $489 |
| Nano 2nd Gen Pen Needle | 26 | $3,790 | $146 |
| Levothyroxine | 171 | $3,450 | $20 |
| Humulin N | 12 | $1,899 | $158 |
| Humulin R | 12 | $1,899 | $158 |
| Liothyronine | 24 | $1,834 | $76 |
| Ultra-Fine Mini Pen Needle | 13 | $1,756 | $135 |
| Alendronate | 140 | $1,335 | $10 |
| Levoxyl | 47 | $1,181 | $25 |
| Rosuvastatin | 11 | $584 | $53 |
| Glipizide Er | 19 | $568 | $30 |
| Metformin Hcl Er | 47 | $566 | $12 |
| Atorvastatin | 59 | $505 | $9 |
| Metformin | 50 | $255 | $5 |
| Lisinopril | 12 | $168 | $14 |
| Methimazole | 13 | $167 | $13 |
| Amlodipine Besylate | 12 | $79 | $7 |
| Glipizide | 15 | $75 | $5 |
2021: 33 drugs
| Trulicity | 95 | $114,983 | $1,210 |
| Ozempic | 63 | $93,838 | $1,489 |
| Jardiance | 70 | $91,074 | $1,301 |
| Novolog Flexpen | 32 | $54,443 | $1,701 |
| Forteo | 11 | $43,145 | $3,922 |
| Humalog Kwikpen U-100 | 24 | $29,715 | $1,238 |
| Lantus Solostar | 35 | $24,949 | $713 |
| Tresiba Flextouch U-100 | 22 | $22,550 | $1,025 |
| Synthroid | 92 | $10,868 | $118 |
| Humalog | 12 | $8,697 | $725 |
| Lantus | 14 | $8,676 | $620 |
| Basaglar Kwikpen U-100 | 20 | $8,574 | $429 |
| Farxiga | 11 | $8,301 | $755 |
| Insulin Lispro Kwikpen U-100 | 12 | $5,954 | $496 |
| Levothyroxine | 151 | $3,837 | $25 |
| Nano 2nd Gen Pen Needle | 19 | $3,047 | $160 |
| Ultra-Fine Mini Pen Needle | 19 | $2,254 | $119 |
| Humulin N | 13 | $2,057 | $158 |
| Humulin R | 13 | $2,057 | $158 |
| Liothyronine | 28 | $1,958 | $70 |
| Armour Thyroid | 19 | $1,412 | $74 |
| Levoxyl | 45 | $1,411 | $31 |
| Ultra-Fine Nano Pen Needle | 13 | $1,368 | $105 |
| Alendronate | 131 | $1,177 | $9 |
| Atorvastatin | 56 | $894 | $16 |
| Metformin Hcl Er | 62 | $893 | $14 |
| Rosuvastatin | 13 | $646 | $50 |
| Glipizide Er | 15 | $442 | $29 |
| Metformin | 38 | $290 | $8 |
| Prednisone | 11 | $274 | $25 |
| Gabapentin | 13 | $180 | $14 |
| Methimazole | 11 | $169 | $15 |
| Glipizide | 12 | $58 | $5 |
2020: 25 drugs
| Forteo | 23 | $84,189 | $3,660 |
| Trulicity | 41 | $53,454 | $1,304 |
| Jardiance | 51 | $44,294 | $869 |
| Novolog Flexpen | 36 | $37,769 | $1,049 |
| Ozempic | 17 | $21,614 | $1,271 |
| Lantus Solostar | 34 | $19,884 | $585 |
| Humalog Kwikpen U-100 | 22 | $15,725 | $715 |
| Tradjenta | 25 | $14,862 | $594 |
| Tresiba Flextouch U-100 | 18 | $13,624 | $757 |
| Synthroid | 100 | $11,163 | $112 |
| Basaglar Kwikpen U-100 | 11 | $5,069 | $461 |
| Levothyroxine | 148 | $4,000 | $27 |
| Ultra-Fine Nano Pen Needle | 31 | $3,131 | $101 |
| Ultra-Fine Mini Pen Needle | 23 | $2,993 | $130 |
| Liothyronine | 25 | $1,358 | $54 |
| Levoxyl | 34 | $1,292 | $38 |
| Alendronate | 95 | $984 | $10 |
| Atorvastatin | 48 | $879 | $18 |
| Rosuvastatin | 18 | $692 | $38 |
| Armour Thyroid | 12 | $549 | $46 |
| Metformin Hcl Er | 39 | $481 | $12 |
| Ezetimibe | 11 | $383 | $35 |
| Metformin | 32 | $308 | $10 |
| Glipizide Er | 11 | $182 | $17 |
| Methimazole | 13 | $99 | $8 |
2019: 25 drugs
| Forteo | 25 | $86,532 | $3,461 |
| Humalog Kwikpen U-100 | 53 | $51,976 | $981 |
| Novolog Flexpen | 41 | $32,657 | $797 |
| Lantus Solostar | 35 | $23,482 | $671 |
| Trulicity | 19 | $23,216 | $1,222 |
| Victoza 3-Pak | 16 | $18,767 | $1,173 |
| Levemir Flextouch | 16 | $12,061 | $754 |
| Bydureon | 14 | $9,906 | $708 |
| Synthroid | 92 | $9,550 | $104 |
| Jardiance | 11 | $7,392 | $672 |
| Tresiba Flextouch U-100 | 12 | $6,914 | $576 |
| Basaglar Kwikpen U-100 | 18 | $5,535 | $308 |
| Ultra-Fine Nano Pen Needle | 36 | $3,401 | $94 |
| Levothyroxine | 120 | $3,150 | $26 |
| Ultra-Fine Mini Pen Needle | 21 | $2,395 | $114 |
| Liothyronine | 21 | $1,380 | $66 |
| Levoxyl | 37 | $1,360 | $37 |
| Alendronate | 101 | $947 | $9 |
| Rosuvastatin | 11 | $685 | $62 |
| Metformin Hcl Er | 37 | $509 | $14 |
| Atorvastatin | 31 | $365 | $12 |
| Glipizide | 16 | $291 | $18 |
| Metformin | 27 | $255 | $9 |
| Methimazole | 14 | $155 | $11 |
| Glipizide Er | 11 | $143 | $13 |
2018: 27 drugs
| Humalog Kwikpen U-100 | 67 | $45,951 | $686 |
| Forteo | 13 | $42,715 | $3,286 |
| Victoza 3-Pak | 23 | $30,819 | $1,340 |
| Novolog Flexpen | 44 | $30,622 | $696 |
| Lantus Solostar | 48 | $26,423 | $550 |
| Trulicity | 19 | $17,933 | $944 |
| Bydureon | 21 | $15,652 | $745 |
| Levemir Flextouch | 24 | $15,295 | $637 |
| Toujeo Solostar | 14 | $13,292 | $949 |
| Humalog | 13 | $12,949 | $996 |
| Jardiance | 17 | $12,775 | $751 |
| Januvia | 15 | $12,411 | $827 |
| Basaglar Kwikpen U-100 | 25 | $7,472 | $299 |
| Synthroid | 80 | $7,438 | $93 |
| Ultra-Fine Nano Pen Needle | 52 | $3,983 | $77 |
| Levothyroxine | 111 | $2,852 | $26 |
| Ultra-Fine Mini Pen Needle | 31 | $2,742 | $88 |
| Rosuvastatin | 20 | $1,459 | $73 |
| Liothyronine | 16 | $1,131 | $71 |
| Levoxyl | 32 | $847 | $26 |
| Metformin Hcl Er | 59 | $622 | $11 |
| Alendronate | 73 | $591 | $8 |
| Metformin | 35 | $369 | $11 |
| Glipizide Er | 13 | $281 | $22 |
| Atorvastatin | 23 | $259 | $11 |
| Glipizide | 12 | $178 | $15 |
| Methimazole | 18 | $164 | $9 |
2017: 27 drugs
| Victoza 3-Pak | 49 | $46,295 | $945 |
| Lantus Solostar | 75 | $30,825 | $411 |
| Novolog Flexpen | 50 | $29,479 | $590 |
| Humalog Kwikpen U-100 | 55 | $28,971 | $527 |
| Humalog | 12 | $23,283 | $1,940 |
| Androgel | 21 | $20,848 | $993 |
| Humulin R U-500 Kwikpen | 12 | $20,230 | $1,686 |
| Trulicity | 27 | $18,722 | $693 |
| Januvia | 23 | $17,364 | $755 |
| Levemir Flextouch | 33 | $13,373 | $405 |
| Jardiance | 18 | $9,514 | $529 |
| Tradjenta | 16 | $7,438 | $465 |
| Tresiba Flextouch U-100 | 12 | $6,686 | $557 |
| Toujeo Solostar | 12 | $6,639 | $553 |
| Synthroid | 70 | $5,033 | $72 |
| Lantus | 11 | $3,769 | $343 |
| Levothyroxine | 121 | $3,130 | $26 |
| Ultra-Fine Mini Pen Needle | 38 | $2,507 | $66 |
| Ultra-Fine Nano Pen Needle | 44 | $2,141 | $49 |
| Rosuvastatin | 19 | $1,635 | $86 |
| Raloxifene | 12 | $1,118 | $93 |
| Liothyronine | 21 | $849 | $40 |
| Alendronate | 91 | $503 | $6 |
| Metformin Hcl Er | 63 | $502 | $8 |
| Levoxyl | 16 | $334 | $21 |
| Atorvastatin | 27 | $333 | $12 |
| Metformin | 32 | $300 | $9 |
2016: 20 drugs
| Victoza 3-Pak | 25 | $23,950 | $958 |
| Lantus Solostar | 59 | $22,200 | $376 |
| Novolog Flexpen | 41 | $19,607 | $478 |
| Humalog Kwikpen U-100 | 36 | $16,667 | $463 |
| Humalog | 12 | $16,491 | $1,374 |
| Levemir Flextouch | 18 | $8,502 | $472 |
| Tradjenta | 15 | $6,806 | $454 |
| Synthroid | 63 | $4,319 | $69 |
| Bd Ultra-Fine Pen Needle | 66 | $3,558 | $54 |
| Levothyroxine | 86 | $2,116 | $25 |
| Liothyronine | 22 | $554 | $25 |
| Gabapentin | 19 | $374 | $20 |
| Levoxyl | 21 | $361 | $17 |
| Metformin Hcl Er | 30 | $349 | $12 |
| Metformin | 34 | $289 | $8 |
| Alendronate | 41 | $239 | $6 |
| Atorvastatin | 36 | $238 | $7 |
| Simvastatin | 18 | $145 | $8 |
| Estradiol | 11 | $79 | $7 |
| Amlodipine Besylate | 12 | $67 | $6 |
2015: 17 drugs
| Humulin R U-500 | 14 | $32,193 | $2,300 |
| Lantus Solostar | 62 | $23,295 | $376 |
| Victoza 3-Pak | 27 | $18,611 | $689 |
| Novolog Flexpen | 36 | $15,159 | $421 |
| Levemir Flextouch | 25 | $11,118 | $445 |
| Humalog Kwikpen U-100 | 29 | $9,524 | $328 |
| Synthroid | 62 | $4,443 | $72 |
| Bd Ultra-Fine Pen Needle | 52 | $2,846 | $55 |
| Liothyronine | 27 | $1,258 | $47 |
| Levothyroxine | 49 | $1,238 | $25 |
| Atorvastatin | 15 | $345 | $23 |
| Metformin | 27 | $181 | $7 |
| Metformin Hcl Er | 20 | $157 | $8 |
| Losartan | 11 | $123 | $11 |
| Gabapentin | 13 | $89 | $7 |
| Simvastatin | 14 | $89 | $6 |
| Estradiol | 11 | $56 | $5 |
2014: 33 drugs
| Lantus Solostar | 79 | $30,303 | $384 |
| Humalog | 71 | $29,780 | $419 |
| Humulin R | 12 | $29,219 | $2,435 |
| Januvia | 32 | $18,788 | $587 |
| Novolog Flexpen | 44 | $14,832 | $337 |
| Lantus | 54 | $13,266 | $246 |
| Victoza 3-Pak | 23 | $12,930 | $562 |
| Synthroid | 170 | $10,817 | $64 |
| Levemir Flexpen | 17 | $6,412 | $377 |
| Novolog | 16 | $4,977 | $311 |
| Bd Ultra-Fine Pen Needle | 79 | $3,986 | $50 |
| Lovaza | 15 | $3,130 | $209 |
| Liothyronine | 27 | $1,760 | $65 |
| Levothyroxine | 66 | $1,546 | $23 |
| Cytomel | 17 | $1,079 | $63 |
| Ibandronate | 13 | $915 | $70 |
| Insulin | 23 | $846 | $37 |
| Atorvastatin | 26 | $823 | $32 |
| Insulin | 23 | $778 | $34 |
| Metformin | 67 | $749 | $11 |
| Novofine 32 | 13 | $669 | $51 |
| Simvastatin | 33 | $336 | $10 |
| Losartan | 16 | $316 | $20 |
| Metformin Hcl Er | 27 | $213 | $8 |
| Terazosin | 16 | $185 | $12 |
| Carvedilol | 12 | $176 | $15 |
| Methimazole | 14 | $148 | $11 |
| Amlodipine Besylate | 14 | $138 | $10 |
| Glimepiride | 13 | $133 | $10 |
| Lisinopril | 18 | $119 | $7 |
| Gabapentin | 13 | $113 | $9 |
| Alendronate | 16 | $102 | $6 |
| Hydrochlorothiazide | 14 | $45 | $3 |
2013: 44 drugs
| Humalog | 111 | $45,438 | $409 |
| Lantus Solostar | 109 | $36,174 | $332 |
| Novolog Flexpen | 108 | $34,965 | $324 |
| Januvia | 64 | $29,118 | $455 |
| Lantus | 93 | $27,668 | $298 |
| Humulin R | 23 | $20,063 | $872 |
| Synthroid | 368 | $18,948 | $51 |
| Levemir Flexpen | 67 | $17,843 | $266 |
| Victoza 3-Pak | 33 | $17,382 | $527 |
| Novolog | 24 | $11,450 | $477 |
| Byetta | 15 | $7,066 | $471 |
| Crestor | 27 | $6,880 | $255 |
| Bd Ultra-Fine Pen Needle | 135 | $6,029 | $45 |
| Androgel | 14 | $5,114 | $365 |
| Liothyronine | 69 | $4,683 | $68 |
| Fenofibrate | 21 | $3,362 | $160 |
| Diovan | 12 | $2,886 | $241 |
| Atorvastatin | 57 | $2,199 | $39 |
| Levothyroxine | 126 | $2,079 | $17 |
| Metformin | 122 | $1,972 | $16 |
| Ibandronate | 22 | $1,944 | $88 |
| Pioglitazone | 13 | $1,822 | $140 |
| Insulin | 56 | $1,629 | $29 |
| Insulin | 33 | $1,334 | $40 |
| Levoxyl | 57 | $1,324 | $23 |
| Valsartan-Hydrochlorothiazide | 11 | $1,320 | $120 |
| Simvastatin | 68 | $1,164 | $17 |
| Cytomel | 18 | $881 | $49 |
| Metformin Hcl Er | 39 | $832 | $21 |
| Losartan | 41 | $829 | $20 |
| Desmopressin Acetate | 12 | $749 | $62 |
| Carvedilol | 35 | $669 | $19 |
| Calcitriol | 23 | $551 | $24 |
| Alendronate | 34 | $506 | $15 |
| Pravastatin | 22 | $474 | $22 |
| Gabapentin | 26 | $418 | $16 |
| Methimazole | 27 | $355 | $13 |
| Lisinopril | 42 | $328 | $8 |
| Glimepiride | 34 | $277 | $8 |
| Amlodipine Besylate | 20 | $267 | $13 |
| Omeprazole | 12 | $197 | $16 |
| Terazosin | 16 | $179 | $11 |
| Atenolol | 12 | $94 | $8 |
| Hydrochlorothiazide | 11 | $65 | $6 |
Money from drug and device companies
$246 in 2025
| 2025 | 2 | 2 | None | $246 |
| 2023 | 1 | 1 | None | $83 |
| 2019 | 1 | 1 | None | $12 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Corcept Therapeutics | Korlym | $125 | 1 payment
|
| Ascendis Pharma Endocrinology | Yorvipath | $122 | 1 payment
|
See all 2 published payments
| Corcept Therapeutics | Meals · 2025-07-14 | Korlym | $125 |
| Ascendis Pharma Endocrinology | Meals · 2025-04-05 | Yorvipath | $122 |
See earlier years (2023, 2019)
2023: $83
| Beta Bionics | Ilet Bionic Pancreas | $83 | 1 payment
|
2019: $12
| Mannkind | Afrezza | $12 | 1 payment
|
Professional record
- NPI
- 1770562134
- Licence
- CA A61454California A61454: Current · expires 2029-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2025 Soquel Ave, Santa Cruz, CA, 95062
- NPI first listed
- 2006-01-13
- NPI last updated
- 2011-09-14
This is when the NPI record was last certified, not a medical board exam.